Trial reportBMC anesthesiology2025
The electromyographic single twitch stimulation for monitoring the effect of rocuronium on vocal cord opening - a randomised controlled trial.
Trial report in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe European Society of Anaesthesiology and Intensive Care recommends the use of neuromuscular blocking drugs for tracheal intubation, but the monitoring is difficult, because the parameters are mostly relative values (e.g. Train-of-four ratio), which show no or only weak correlations to the vocal cord aperture. We investigated the predictive effect of the quantitative single twitch (0.3 ms duration supramaximal stimulus, frequency 0.1 Hz) to estimate vocal cord aperture (primary endpoint). Secondarily, we focused on rocuronium dose-related differences between single twitch amplitude and maximum vocal cord aperture.
methodsThirty-six adult patients undergoing elective surgery with tracheal intubation using rocuronium were included. Patients received remifentanil and propofol for induction of anaesthesia before the neuromuscular block baseline was measured electromyographically using the single twitch stimulation pattern of the ulnar nerve from the abductor digiti minimi muscle. A video-laryngoscope was inserted to document baseline conditions before the patient received either 0.3 or 0.9 mg/kg IBW rocuronium. The vocal cord area was continuously videorecorded for four minutes, before the trachea was intubated.
resultsThirty-five patients completed the study; 18 received 0.3 and 17 received 0.9 mg/kg IBW rocuronium. Data showed a strong correlation between single twitch amplitude and vocal cord aperture (bootstrapped Pearson's coefficients, median ± IQR: -0.58 ± 0.22 in rocuronium 0.3 and -0.74 ± 0.18 in rocuronium 0.9 mg/kg IBW; p < 0.001), meaning that the single twitch amplitude may be a reliable predictor of vocal cord opening. The higher rocuronium dose caused a stronger correlation, lower inter-patient variability, and a steeper single twitch decrease, but the effect on the maximum vocal cord aperture was comparable to that in the 0.3 mg/kg IBW rocuronium group.
conclusionsThe quantitative, electromyographic single twitch stimulation pattern can dose-independent predict vocal cord opening after rocuronium administration.
trial registrationThe study was registered at the German Clinical Trials Register on the 10th of July 2020 (DRKS00021433) prior to enrolment of the patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.